StemCorp

What StemCorp does

StemCorp is a privately held Brazilian biomedical services company headquartered in Sao Paulo that operates as a dedicated mesenchymal stem cell (MSC) banking center. The company collects, processes, cryopreserves, expands, and characterizes MSCs drawn from three biological sources: umbilical cord tissue at birth, dental pulp from deciduous teeth, and adipose tissue collected during surgical procedures. It is the only provider in Brazil offering all three collection modalities, and it claims to be the first Brazilian center to internationally validate the use of umbilical cord tissue (as distinct from cord blood) as a rich MSC source. Customers are primarily Brazilian families — expectant parents, families with children losing baby teeth, and adults undergoing elective or medically necessary procedures such as cesarean sections or liposuction.

Name

StemCorp

Legal name

StemCorp – Serviços Biomédicos Ltda.

Website

https://stemcorp.com.br

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

StemCorp is a Sao Paulo-based stem cell banking company that collects, processes, and cryopreserves mesenchymal stem cells from umbilical cord tissue, dental pulp, and adipose tissue for Brazilian families and adult patients pursuing regenerative medicine options.

Ownership category

akta.pro rank

Product category

Stem Cell Banking Services

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Stem cell banking
• Mesenchymal stem cells
• Umbilical cord storage
• Cryopreservation services
• Regenerative medicine

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Stem Cell Storage Services: Private stem cell banking services for umbilical cord tissue, dental pulp, and adipose tissue. Customers pay for collection, processing, cryopreservation, and ongoing storage, with various plan options available.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

StemCorp collects, processes, and cryopreserves mesenchymal stem cells (MSCs) sourced from three biological materials — umbilical cord tissue at birth, dental pulp from deciduous (baby) teeth, and adipose tissue from surgical procedures — at its ISO 7 Class 10,000 laboratory licensed by ANVISA. The firm delivers cellular expansion, characterization, and indefinite -196°C long-term storage for potential future regenerative medicine use, and sells these banking services directly to families and adults in Brazil.

Product overview

StemCorp is a specialized stem cell center offering collection, processing, cryopreservation, and expansion of mesenchymal stem cells from three distinct biological sources: umbilical cord tissue, dental pulp from deciduous teeth, and adipose tissue. The company operates an ISO 7, Class 10,000 laboratory licensed by Brazilian health authorities (Anvisa/Vigilância Sanitária), providing comprehensive stem cell banking services for families and patients seeking access to regenerative medicine therapies. Services include initial collection, cellular expansion, long-term cryopreservation at -196°C, and cell characterization for clinical use.

Differentiator

Problem solved

Functional benefit

Products and services

• Umbilical Cord Tissue Stem Cell Collection (Coleta de Células-Tronco do Cordão Umbilical) Collection, processing, and cryopreservation of mesenchymal stem cells (MSCs) from umbilical cord tissue, performed immediately after birth with no risk to mother or baby. Targeted at expectant parents who wish to bank autologous MSCs for potential future regenerative medicine use.
• Baby Tooth Dental Pulp Stem Cell Collection (Coleta de Células-Tronco da Polpa do Dente) Collection of mesenchymal stem cells from the dental pulp of deciduous (baby) teeth, performed when teeth are naturally loose or during dental procedures. Targeted at families with children in the tooth-loss phase who want a non-invasive, painless collection opportunity to preserve younger autologous stem cells for future therapeutic use.
• Adipose Tissue Stem Cell Collection (Coleta de Células-Tronco do Tecido Adiposo) Collection of mesenchymal stem cells from adipose (fat) tissue obtained during cesarean section, liposuction, or minimally invasive biopsy under local anesthesia. Targeted at adults undergoing these surgical procedures who want to bank younger autologous stem cells for potential aesthetic and regenerative applications, including anti-aging treatments.
• Mesenchymal Stem Cell Cryopreservation Storage (Armazenamento e Criopreservação de Células-Tronco) Long-term cryopreservation of mesenchymal stem cells at -196°C, maintaining cell viability indefinitely for future therapeutic use. Includes laboratory cellular expansion to generate clinically sufficient quantities and cellular characterization to validate sample quality. Sold as an ongoing multi-year storage contract tied to a collection source.

Quantifiable outcome

• Stem cells cryopreserved at -196°C can maintain viability indefinitely, as demonstrated by cells frozen for ~25 years that preserved all stem cell characteristics upon thawing.
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Universidade de São Paulo (USP)coreStrategic or Co-development PartnerStemCorp was founded by researchers from the University of São Paulo and maintains ongoing research associations with USP. The company was born from over 20 years of research at USP's Human Genome and Stem Cell Research Center, with supervision from Dr. Mayana Zatz. USP represents the foundational research backbone of StemCorp's operations.
• Harvard UniversitycoreStrategic or Co-development PartnerStemCorp maintains research associations with Harvard University in the United States, seeking to stay aligned with the most innovative global stem cell research. The company references ongoing collaboration aimed at advancing stem cell science in Brazil.
• Centro de Pesquisa Sobre o Genoma Humano e Células-Tronco (Human Genome and Stem Cell Research Center)coreStrategic or Co-development PartnerStemCorp's founders developed their research at this center, supervised by Dr. Mayana Zatz. The center represents the scientific origin of the company and continues to serve as a research backbone.
• Instituto CohenminorStrategic or Co-development PartnerStemCorp collaborates with Instituto Cohen in testing the use of mesenchymal stem cells on a biomembrane for cartilage repair treatment. This is an active clinical trial collaboration in orthopedics.
• Hospital Israelita Albert EinsteinminorStrategic or Co-development PartnerStemCorp collaborates with Hospital Israelita Albert Einstein alongside Instituto Cohen on testing mesenchymal stem cell applications in biomembranes for cartilage treatment. This is a three-way clinical research collaboration in orthopedics.
• Anvisa / Brazilian Health Regulatory AuthoritiescoreOthersStemCorp is regulated and licensed by ANVISA and health surveillance authorities as a Cell Processing Center for production of cells for human infusion. The company is positioned to conduct clinical trials pending regulatory approval.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• CordVida: Brazilian private stem cell bank offering cord blood and cord tissue storage to families; directly competes with StemCorp in the same geography with overlapping customer base of expectant parents.
• ViaCord: US-based family cord blood and cord tissue bank owned by CooperSurgical; competes with the same expectant-parent segment using a similar recurring-storage model.
• Cells4Life: UK-based private stem cell bank storing cord blood and cord tissue; comparable D2C subscription model with similar regulatory and consumer-trust dynamics in a single home market.
• Cryo-Cell International: US-based public company focused on private cord blood and cord tissue banking with subscription revenue model; highly comparable business model, regulatory framework, and customer journey.
• Future Health Biobank: International stem cell bank offering cord blood, cord tissue, and dental pulp storage across multiple geographies; directly comparable multi-source MSC banking proposition.
• Bioeden: Specialist in dental pulp stem cell banking from baby teeth; directly comparable to StemCorp's dental pulp collection service, with similar consumer audience and recurring storage model.
• Cord Blood Registry (CBR): One of the largest US family cord blood banks, now part of CooperSurgical; comparable consumer banking proposition, scientific positioning, and multi-year storage contracts.

Broad incumbents

• StemCyte: Global cord blood bank with both public and private banking operations; comparable in storage technology and customer base, but broader scope including public banking relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/stemcorp
• YouTubeyoutube.com/channel/UCgJDexcqcPxUOJ1eiyAueKA
• Facebookfacebook.com/stemcorp
• Instagraminstagram.com/stemcorp

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about StemCorp